Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
复制标题
DOI：
10.3332/ecancer.2020.ed98
复制
发表时间：
2020-04-03
影响因子：
1.8
通讯作者：
Van Hemelrijck, Mieke
中科院分区：
文献类型：
--
作者：
Russell, Beth;Moss, Charlotte;Van Hemelrijck, Mieke
有几份报告指出嗅觉丧失和味觉丧失可能是COVID-19的症状。这在肿瘤学中特别令人感兴趣，因为接受一些癌症治疗（例如化疗或免疫治疗）的患者通常会经历类似的症状作为副作用。本报告的目的是总结嗅觉丧失和味觉丧失（一种新出现的COVID-19症状）存在的证据，以便更好地告知肿瘤患者和临床医生。目前，没有已发表的证据或病例报告指出嗅觉丧失或味觉丧失是COVID-19的症状。尽管如此，神经病学专家认为，这些症状的出现可能会在可能的情况下作为疾病检测的触发因素，或者可能是自我隔离的新标准。虽然目前需要更多数据来加强我们对COVID-19症状的了解，但在全身抗癌治疗的背景下担心嗅觉丧失或味觉丧失的肿瘤患者应联系其急性肿瘤支持热线寻求建议。
There have been several reports noting anosmia and ageusia as possible symptoms of COVID-19. This is of particular interest in oncology since patients receiving some cancer treatments such as chemotherapy or immune therapy often experience similar symptoms as side-effects. The purpose of this report was to summarise the evidence on the existence of anosmia and ageusia an emerging COVID-19 symptoms in order to better inform both oncology patients and clinicians. Currently, there is no published evidence or case reports noting anosmia or ageusia as symptoms of COVID-19. Nevertheless, experts in rhinology have suggested that the onset of such symptoms could either act as a trigger for testing for the disease where possible, or could be a new criterion to self-isolate. Whilst more data is currently needed to strengthen our knowledge of the symptoms of COVID-19, oncology patients who are concerned about anosmia or ageusia in the context of their systemic anticancer therapy should contact their acute oncology support line for advice.